Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin in Early Myelodysplastic Syndrome
NCT00017550Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2000
- Primary completion
- Nov 2003
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of antithymocyte globulin in myelodysplastic syndrome (MDS), sponsored by Sanofi. Started Sep 2000; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00017550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017550.